Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of CBD Extract in Healthy Adults
NCT04280289Phase 1Completed
- Sponsor
- University of Mississippi
- Start
- Feb 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of cannabidiol in epilepsy, sponsored by University of Mississippi. Primary endpoints: Plasma concentration of minor phytocannabinoids and metabolites and Urine concentration of minor phytocannabinoids and metabolites. Started Feb 2021; status: completed.
02
Drugs
cannabidiol
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT04280289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04280289.